http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ceda0e9a3c7af9da4d73371ab6568a6
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Rizzieri |
| name | David A Rizzieri David A. Rizzieri |
| given-name | David A. David A |
| organization-name | Duke University Medical Center, Durham NC 27710; Marrow and Stem Cell Transplantation Program at the Duke University Medical Center, Durham, North Carolina. Department of Medicine; Duke University Medical Center; Durham NC USA Novant Health Cancer Institute, Winston-Salem, NC, USA Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Duke Cancer Institute, Durham, North Carolina Medicine, and From the Marrow and Stem Cell Transplantation Program, Duke University Medical Center, Durham, NC. Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester,... 13Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC Duke University Medical Center, Division of Medical Oncology and Transplantation and the Duke Oncology Consortium, Durham, North Carolina 27710, USA. [email protected] Ohio State University, Columbus, OH From the Division of Medical Oncology and Transplantation, Duke University Medical Center, and Duke Oncology Consortium, Durham, NC. Duke University Medical Center, Durham, NC From the Blood and Marrow Transplant Program, Markey Cancer Center, Division of Hematology/Oncology, University of Kentucky Medical Center, Lexington; Division of Oncology and Bone Marrow Transplantation, Duke University Medical Center, Durham, NC; and Hematology-Oncology Division, University of Pennsylvania Medical Center, Philadelphia. Duke University Medical Center Durham North Carolina Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC; and Duke Cancer Institute, Durham, NC Duke University School of Medicine Durham North Carolina USA Brian C. Shaffer and Martin Tallman, Memorial Sloan Kettering Cancer Center; Adriana K. Malone, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; Ran Reshef, Columbia University Medical Center, New York; Mark Litzow, Mayo Clinic Rochester; Jane Liesveld, University of Rochester Medical Center, Rochester; Peter H. Wiernik, Our Lady of Mercy Medical Center, Bronx, NY; Kwang Woo Ahn, Zhen-Huan Hu, and Wael Saber, Center for International Blood and Marrow Transplant Research, Medical College... From the Departments of Pathology (Drs Lagoo, Gong, Stenzel, Goodman, and Buckley) and Medicine (Drs Chao, Gasparetto, Long, and Rizzieri), Duke University Medical Center, Durham, NC. Dr Stenzel is currently medical director at Abbott Molecular, Des Plaines, Ill 1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; 4Duke Cancer Institute, Duke University, Durham, North Carolina. Division of Hematologic Malignancies and Cellular Therapy Duke University Durham North Carolina From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana–Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) — all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham,... Duke University Medical Center, Durham NC; Division of Hematologic Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC 27710, USA. Duke University Medical Center Durham NC USA Division of Hematologic Malignancies & Cellular Therapy Duke University Medical Center Durham NC USA Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina 6Novant Health Cancer Institute, Winston-Salem, NC From the Blood and Marrow Transplant Program, Markey Cancer Center, Division of Hematology/Oncology, University of Kentucky Medical Center, Lexington Division of Oncology and Bone Marrow Transplantation, Duke University Medical Center, Durham, NC; and the Department of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA. Duke University Medical Center, Durham, NC; 6Novant Health Cancer Institute, Charlotte, Durham, North Carolina. Division of Hematologic Malignancies and Cellular Therapy Duke University Medical Center Durham North Carolina From the Division of Medical Oncology, Department of Medicine, Duke University Medical Center; and the Institute for Genomic Sciences and Policy, Duke University, Durham, NC; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands; and the Laboratory of Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität-Campus Grobhadern, Munich, Germany. Duke Cancer Institute, Durham, NC, USA Duke University Medical Center, Durham, North Carolina 27710, USA. [email protected] 2Department of Medicine, Duke University Medical Center, Durham, North Carolina From the Centre Hospitalier Universitaire Sainte-Justine, Universite de Montreal, Montreal; Princess Margaret Hospital, Ontario; and British Columbia's Children's Hospital, Vancouver, Canada; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; and Children's Hospital of Wisconsin, Milwaukee, WI; Hospital A. Michallon, CHU de Grenoble, Grenoble, France; Morgan Stanley Children's Hospital of New York–Presbyterian, New York, NY; Baylor College of Medicine; and M. D.... Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina. From the Department of Medicine, Division of Oncology and Stem Cell Transplantation, Duke University Medical Center, Durham, NC; the Department of Pathology, Division of Hematopathology, Duke University Medical Center, Durham, NC; the Department of Pathology, Division of Immunohistochemistry, Duke University Medical Center, Durham, NC; and the Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Durham, NC. DUKE CANCER INSTITUTE Duke University Medical Center – Medicine, 1149 North Pavilion Duke University Durham, NC 27710, USA Cellular Therapy Duke University Medical Center Durham NC USA Department of Medicine, Division of Oncology and Stem Cell Transplantation, Duke University Medical Center 1Duke University Medical Center, Durham, North Carolina; Philippe Armand and Edie Weller, Dana-Farber Cancer Institute; David E. Avigan, Beth Israel Deaconess Medical Center; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Arnon Nagler, Chaim Sheba Medical Center, Tel-Hashomer; Reuven Or, Hadassah Medical Center, Jerusalem; Rinat Rotem-Yehudar, CureTech, Yavne, Israel; Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus; Hillard M. Lazarus, Case Western Reserve University and University Hospitals... From the Department of Medicine, Division of Cellular Therapy; Department of Biostatistics; Department of Pathology, Division of Hematopathology; and Department of Medicine, Division of Oncology, Duke University Medical Center, Durham, NC; and the Department of Medicine, Division of Stem Cell Transplantation, Vancouver University, Vancouver, British Columbia, Canada From the Division of Medical Oncology and Transplantation, Duke University Medical Center, and the Duke Oncology Consortium, Durham, NC. 1Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.; 3Duke Cancer Institute, Duke University, Durham, North Carolina. 50Novant Health Cancer Institute, Winston Salem, NC Department of Medicine, Duke University Medical Center, Durham, NC 27710; Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 27710; |
Incoming Links
Showing number of triples: 1 to 185 of 185.